| Literature DB >> 28115893 |
Recep Palamutoğlu1, Cemalettin Sariçoban2.
Abstract
The effect of addition commercial fish collagen hydrolysate and encapsulated fish collagen hydrolysate on the quality characteristics of sucuk (a traditional Turkish dry-fermented sausage) was investigated. Fish collagen hydrolysates were encapsulated with maltodextrin (MD) which has two different dextrose equivalent (12DE and 19 DE), with two different types of core/coating material ratios (10% peptide : 90% MD, 20% peptide : 80% MD). Than six group of sucuk dough (control, peptide, MD1210, MD1220, MD1910, MD1920) prepared and naturally fermented. The effects of the ripening period (28 d), treatment (peptide and encapsulated peptide addition) 'ripening period × treatment' interaction on sucuk's pH, lactic acid contents, aw values and moisture contents were statistically significant (p<0.01). The pH, moisture and aw decrease and lactic acid concentration increses during ripening period. The highest pH was observed with peptide added group (5.41), and encapsulated peptide added groups (4.76-4.77) were lower than the control group (5.26). Lactic acid concentration was affected from treatment and all treatment groups lactic acid concentration (0.185-0.190%) were higher than the control group (0.164%). Antioxidant and Angiotensin converting enzyme inhibition activities of water soluble protein extracts were significantly (p<0.01) increased during ripening time. Antioxidant activity reached the highest level at 28th d. There was no significant increase observed after fermentation for both activities. Antioxidant activity of encapsulated peptide added (%39.56-40.48) groups were higher than control (34.28%) and peptide added (33.99%) groups except MD1920 (38.30%). The effect of the ripening period of the sucuk samples on TBA values was found to be statistically significant (p<0.01) while treatment and 'ripening period × treatment' interaction were not to be significant (p<0.05). The value of hardness was the highest in the encapsulated peptide added groups (29.27, 35.83 N), and it was 20.40 N and 15.41 N in the peptide added group and the control group respectively.Entities:
Keywords: TBA; antioxidant; encapsulated collagen hydrolysate; sucuk; texture
Year: 2016 PMID: 28115893 PMCID: PMC5243966 DOI: 10.5851/kosfa.2016.36.6.807
Source DB: PubMed Journal: Korean J Food Sci Anim Resour ISSN: 1225-8563 Impact factor: 2.622
Duncan results of effect of treatments on moisture, protein, oil and ash content of sucuks on day 0th and 14th
| Day | Treatment | Moisture | Protein (%) | Oil (%) | Ash (%) |
|---|---|---|---|---|---|
| 0 | Control | 52.02 ± 1.53 | 23.13 ± 2.89 | 21.51 ± 2.75 | 1.51 ± 0.22 |
| Peptide | 52.80 ± 0.67 | 23.13 ± 1.44 | 22.33 ± 1.38 | 1.74 ± 0.06 | |
| MD1210 | 52.66 ± 2.08 | 19.54 ± 0.47 | 27.45 ± 7.50 | 1.33 ± 0.08 | |
| MD1220 | 52.10 ± 1.52 | 18.42 ± 0.69 | 23.53 ± 5.66 | 1.51 ± 0.15 | |
| MD1910 | 52.34 ± 1.14 | 20.17 ± 0.23 | 20.60 ± 5.26 | 1.40 ± 0.29 | |
| MD1920 | 53.58 ± 0.26 | 22.56 ± 0.59 | 28.08 ± 2.51 | 1.58 ± 0.18 | |
| 14 | Control | 37.72a ± 2.81 | 26.62 ± 2.53 | 34.11 ± 6.35 | 3.47 ± 0.09 |
| Peptide | 34.09b ± 1.80 | 29.40 ± 2.06 | 37.62 ± 3.80 | 2.44 ± 0.30 | |
| MD1210 | 29.93cd ± 0.90 | 30.16 ± 0.47 | 43.37 ± 0.21 | 3.40 ± 0.46 | |
| MD1220 | 29.03d ± 0.45 | 27.90 ± 0.51 | 39.08 ± 1.20 | 3.79 ± 0.35 | |
| MD1910 | 30.28cd ± 1.30 | 28.15 ± 1.00 | 35.90 ± 2.00 | 3.16 ± 0.86 | |
| MD1920 | 32.19bc ± 0.83 | 29.63 ± 1.78 | 39.46 ± 4.07 | 3.05 ± 0.74 |
a-dMean values followed by different superscripts within the same column indicate a statistically significant difference between the mean values (p<0.01). Values represent the mean ± standard error.
Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19).
Effect of ripening time and treatments on pH, lactic acid, water activity, and moisture of sucuk
| Factors | pH | Lactic Acid (%) | Water activity (aw) | Moisture (%) | |||
|---|---|---|---|---|---|---|---|
| Ripening time (d) | |||||||
| 0 | 5.90 ± 0.04a | 0.113 ± 0.019g | 0.953 ± 0.003a | 52.58 ± 1.303a | |||
| 1 | 5.20 ± 0.06b | 0.138 ± 0.022f | 0.954 ± 0.003a | 52.10 ± 1.857a | |||
| 2 | 4.92 ± 0.20c | 0.161 ± 0.014e | 0.948 ± 0.004b | 49.91 ± 1.647b | |||
| 3 | 4.88 ± 0.27d | 0.179 ± 0.014d | 0.945 ± 0.003b | 47.33 ± 2.263c | |||
| 4 | 4.70 ± 0.27g | 0.184 ± 0.017d | 0.940 ± 0.004c | 45.38 ± 2.099d | |||
| 5 | 4.75 ± 0.30f | 0.198 ± 0.017c | 0.937 ± 0.005c | 44.22 ± 3.273d | |||
| 6 | 4.79 ± 0.35e | 0.212 ± 0.023b | 0.933 ± 0.003d | 42.40 ± 3.232e | |||
| 7 | 4.72 ± 0.37fg | 0.210 ± 0.022b | 0.930 ± 0.005e | 42.03 ± 2.278e | |||
| 14 | 4.91± 0.46cd | 0.208 ± 0.026b | 0.891 ± 0.016f | 32.18 ± 3.334f | |||
| 28 | 4.81 ± 0.54e | 0.232 ± 0.012a | 0.802 ± 0.023g | 22.34 ± 2.364g | |||
| Treatment | |||||||
| Control | 5.26 ± 0.29b | 0.164 ± 0.038b | 0.928 ± 0.036a | 43.08 ± 8.199bc | |||
| Peptide | 5.41 ± 0.24a | 0.185 ± 0.032a | 0.927 ± 0.035a | 43.92 ± 8.206ab | |||
| MD1210 | 4.76 ± 0.43c | 0.187 ± 0.038a | 0.918 ± 0.051b | 41.73 ± 9.992d | |||
| MD1220 | 4.77 ± 0.42c | 0.187 ± 0.042a | 0.920 ± 0.052b | 42.82 ± 9.829c | |||
| MD1910 | 4.77 ± 0.43c | 0.189 ± 0.042a | 0.920 ± 0.050b | 42.46 ± 9.612cd | |||
| MD1920 | 4.77 ± 0.44c | 0.190 ± 0.043a | 0.927 ± 0.043a | 44.29 ± 9.795a | |||
a-gMean values followed by different superscripts within the same column indicate a statistically significant difference between the mean values (p<0.01). Values represent the mean ± standard error. 28 d of ripening.
Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19).
Fig. 1.Effect of ‘ripening time × treatment’ interaction on pH of sucuk samples0. Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH-%90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19). 28 d of ripening.
Fig. 2.Effect of ‘ripening time × treatment’ interaction on lactic acid content of sucuk samples. Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19). 28 d of ripening.
Fig. 3.Effect of ‘ripening time × treatment’ interaction on a Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD 1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19). 28 d of ripening.
Fig. 4.Effect of ‘ripening time × treatment’ interaction on moisture of sucuk samples. Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19). 28 d of ripening.
Effect of ripening time and treatments on TBA, Antioxidant activity and ACE inhibition activity of sucuk
| Factors | TBA (mg MDA/kg sample) | Antioxidant Activity (%) | ACE Inhibition Activity (%) |
|---|---|---|---|
| Ripening time (d) | |||
| 0 | 0.480 ± 0.041c | 22.10 ± 6.70d | 37.32 ± 7.48b |
| 1 | 0.519 ± 0.055b | 29.22 ± 8.04c | 37.87 ± 6.04b |
| 3 | 0.673 ± 0.056a | 39.27 ± 8.23b | 43.82 ± 3.97a |
| 7 | 0.648 ± 0.049a | 42.70 ± 10.52ab | 44.15 ± 6.63a |
| 14 | 0.490 ± 0.064c | 46.43 ± 4.63a | 44.99 ± 9.07a |
| 28 | 0.445 ± 0.030d | 46.95 ± 8.56a | 43.54 ± 7.30a |
| Treatment | |||
| Control | 0.533 ± 0.093 | 34.28 ± 9.44b* | 41.77 ± 8.70 |
| Peptide | 0.559 ± 0.120 | 33.99 ± 10.44b | 42.45 ± 8.30 |
| MD1210 | 0.544 ± 0.105 | 39.56 ± 10.73a | 42.43 ± 5.83 |
| MD1220 | 0.544 ± 0.097 | 40.05 ± 13.02a | 43.51 ± 6.70 |
| MD1910 | 0.530 ± 0.082 | 40.48 ± 11.54a | 41.84 ± 7.72 |
| MD1920 | 0.546 ± 0.106 | 38.30 ± 15.76ab | 39.71 ± 7.29 |
a,bMean values followed by different superscripts within the same column indicate a statistically significant difference between the mean values (p<0.01), *;(p<0.05). Values represent the mean ± standard error. 28 d of ripening.
Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19).
Effect of treatments on texture profile analysis of sucuk on 14th d
| Treatment | Hardness (N) | Adhesiveness (Ns) | Springiness (mm) | Cohesiveness | Gumminess (N) | Chewiness (Nxmm) | Resilience |
|---|---|---|---|---|---|---|---|
| Control | 15.41 ± 8.38c | −0.062 ± 0.013 | 1.02 ± 0.047 | 0.78 ± 0.042 | 12.91 ± 6.56 | 13.39 ± 7.28 | 0.89 ± 0.133 |
| Peptide | 20.40 ± 7.30bc | −0.048 ± 0.033 | 0.82 ± 0.183 | 0.78 ± 0.040 | 23.18 ± 10.67 | 19.96 ± 12.47 | 0.78 ± 0.085 |
| MD1210 | 31.08 ± 11.66ab | −0.051 ± 0.026 | 0.80 ± 0.212 | 0.73 ± 0.083 | 21.43 ± 18.13 | 19.35 ± 18.96 | 0.82 ± 0.172 |
| MD1220 | 35.83 ± 5.86a | −0.042 ± 0.028 | 0.97 ± 0.010 | 0.80 ± 0.032 | 34.59 ± 10.45 | 33.67 ± 10.05 | 0.86 ± 0.139 |
| MD1910 | 30.82 ± 9.75ab | −0.046 ± 0.036 | 0.76 ± 0.142 | 0.80 ± 0.040 | 33.07 ± 12.15 | 25.25 ± 8.85 | 0.90 ± 0.201 |
| MD1920 | 29.27 ± 6.53ab | −0.065 ± 0.035 | 0.95 ± 0.217 | 0.81 ± 0.045 | 37.32 ± 15.36 | 36.51 ± 17.01 | 0.96 ± 0.170 |
a-cMean values followed by different superscripts within the same column indicate a statistically significant difference between the mean values (p<0.01). Values represent the mean ± standard error.
Peptide, Free collagen hydrolysate; MD1210, Collagen hydrolysate encapsulated with MD12 (%10 CH- %90 MD12); MD1220, Collagen hydrolysate encapsulated with MD12 (%20 CH- %80 MD12); MD1910, Collagen hydrolysate encapsulated with MD19 (%10 CH- %90 MD19); MD1920, Collagen hydrolysate encapsulated with MD19 (%20 CH- %80 MD19).